{"id":"https://openalex.org/W4282928996","doi":"https://doi.org/10.1158/1538-7445.am2022-3193","title":"Abstract 3193: Impact of stromal protection on in vivo response to ALK targeted therapies in NSCLC","display_name":"Abstract 3193: Impact of stromal protection on in vivo response to ALK targeted therapies in NSCLC","publication_year":2022,"publication_date":"2022-06-15","ids":{"openalex":"https://openalex.org/W4282928996","doi":"https://doi.org/10.1158/1538-7445.am2022-3193"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2022-3193","doi":"https://doi.org/10.1158/1538-7445.am2022-3193","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-3193","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010829737","display_name":"Bina Desai","orcid":"https://orcid.org/0000-0003-0454-7583","observed_orcids":["https://orcid.org/0000-0003-0454-7583"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bina Desai","raw_affiliation_strings":["1H Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1H Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078508762","display_name":"Viktoriya Marusyk","orcid":"https://orcid.org/0009-0004-5736-1365","observed_orcids":["https://orcid.org/0009-0004-5736-1365"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Viktoriya Marusyk","raw_affiliation_strings":["1H Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1H Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023455221","display_name":"Daria Miroshnychenko","orcid":"https://orcid.org/0000-0001-6425-5000","observed_orcids":["https://orcid.org/0000-0001-6425-5000"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daria Miroshnychenko","raw_affiliation_strings":["1H Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1H Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069263867","display_name":"Chandler Gatenbee","orcid":"https://orcid.org/0000-0002-9730-5964","observed_orcids":["https://orcid.org/0000-0002-9730-5964"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chandler Gatenbee","raw_affiliation_strings":["1H Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1H Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012452779","display_name":"Uwe Rix","orcid":"https://orcid.org/0000-0002-8242-2770","observed_orcids":["https://orcid.org/0000-0002-8242-2770"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Uwe Rix","raw_affiliation_strings":["1H Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1H Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069501174","display_name":"Alexander R.A. Anderson","orcid":"https://orcid.org/0000-0002-2536-4383","observed_orcids":["https://orcid.org/0000-0002-2536-4383"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander Anderson","raw_affiliation_strings":["1H Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1H Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064494204","display_name":"Eric B. Haura","orcid":"https://orcid.org/0000-0003-3114-1909","observed_orcids":["https://orcid.org/0000-0003-3114-1909"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Haura","raw_affiliation_strings":["1H Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1H Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009118439","display_name":"Andriy Marusyk","orcid":"https://orcid.org/0000-0002-0087-9575","observed_orcids":["https://orcid.org/0000-0002-0087-9575"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andriy Marusyk","raw_affiliation_strings":["1H Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1H Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I3019308854"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"12_Supplement","first_page":"3193","last_page":"3193"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8809999823570251},{"id":"https://openalex.org/keywords/anaplastic-lymphoma-kinase","display_name":"anaplastic lymphoma kinase","score":0.9100000262260437},{"id":"https://openalex.org/keywords/alk-inhibitors","display_name":"ALK inhibitors","score":0.9350000023841858},{"id":"https://openalex.org/keywords/cancer-associated-fibroblasts","display_name":"cancer-associated fibroblasts","score":0.8830000162124634},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.8970000147819519},{"id":"https://openalex.org/keywords/hepatocyte-growth-factor","display_name":"hepatocyte growth factor","score":0.9620000123977661},{"id":"https://openalex.org/keywords/c-met","display_name":"c-Met","score":0.8700000047683716},{"id":"https://openalex.org/keywords/alectinib","display_name":"alectinib","score":0.9700000286102295},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.8410000205039978},{"id":"https://openalex.org/keywords/tumor-recurrence","display_name":"tumor recurrence","score":0.765999972820282},{"id":"https://openalex.org/keywords/xenografts","display_name":"xenografts","score":0.6200000047683716},{"id":"https://openalex.org/keywords/co-culture","display_name":"co-culture","score":0.5540000200271606},{"id":"https://openalex.org/keywords/conditioned-medium","display_name":"conditioned medium","score":0.8059999942779541}],"concepts":[{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.6673789024353027},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6657639741897583},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.6388460397720337},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5630410313606262},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5621098279953003},{"id":"https://openalex.org/C7876069","wikidata":"https://www.wikidata.org/wiki/Q14873666","display_name":"Paracrine signalling","level":3,"score":0.5567052960395813},{"id":"https://openalex.org/C2776996007","wikidata":"https://www.wikidata.org/wiki/Q2399112","display_name":"Hepatocyte growth factor","level":3,"score":0.5325789451599121},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5054137706756592},{"id":"https://openalex.org/C117643217","wikidata":"https://www.wikidata.org/wiki/Q17824987","display_name":"Anaplastic lymphoma kinase","level":4,"score":0.49806833267211914},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.48506346344947815},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4295036792755127},{"id":"https://openalex.org/C128240485","wikidata":"https://www.wikidata.org/wiki/Q786998","display_name":"Autocrine signalling","level":3,"score":0.42043644189834595},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.42026591300964355},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3677358031272888},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.29993736743927},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2708091139793396},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19861218333244324},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.07358014583587646},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.06444260478019714},{"id":"https://openalex.org/C2776232967","wikidata":"https://www.wikidata.org/wiki/Q6743514","display_name":"Malignant pleural effusion","level":3,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2022-3193","doi":"https://doi.org/10.1158/1538-7445.am2022-3193","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-3193","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4280628241","https://openalex.org/W4380079085","https://openalex.org/W3135763893","https://openalex.org/W4395452825","https://openalex.org/W7116954969","https://openalex.org/W4401937067","https://openalex.org/W7221263580","https://openalex.org/W2982420024","https://openalex.org/W4385409873","https://openalex.org/W4411352726"],"abstract_inverted_index":{"Abstract":[0],"Lung":[1],"cancer":[2,12,108],"accounts":[3],"for":[4,43,444],"most":[5,15],"cancer-related":[6],"death":[7],"worldwide.":[8],"Non-small":[9],"cell":[10],"lung":[11,20],"(NSCLC)":[13],"is":[14,153,163],"prominent":[16],"histological":[17],"subtype":[18],"of":[19,24,29,38,69,75,84,89,105,118,133,145,160,172,183,213,222,236,246,248,264,316,322,338,397,424,440],"cancer.":[21],"About":[22],"5-7%":[23],"NSCLC":[25,436],"shows":[26],"constitutive":[27],"activation":[28],"oncogenic":[30],"anaplastic":[31],"lymphoma":[32],"kinase":[33],"(ALK).":[34],"Though":[35],"clinical":[36],"introduction":[37],"tyrosine":[39],"kinases":[40],"inhibitors":[41],"(TKIs)":[42],"ALK,":[44],"has":[45],"improved":[46],"patient":[47],"survival,":[48],"it":[49],"did":[50],"not":[51,357],"translate":[52],"into":[53],"cures":[54],"as":[55,114,198,200],"acquired":[56],"resistance":[57],"inevitably":[58],"emerges":[59],"in":[60,174,257,275,282,299,349,428,435],"patients":[61],"with":[62,190,219,285],"advanced":[63],"and":[64,139,279,379,384],"metastatic":[65],"cancers.":[66],"While":[67,142],"some":[68],"the":[70,90,115,131,143,158,170,220,234,267,303,395,441],"tumor":[71,91,106,149,187,206,240,300,339],"cells":[72,92,150,207,241],"are":[73,368],"capable":[74],"surviving":[76],"therapy":[77],"due":[78],"to":[79,86,147,176,239,251,266,289,359,363,394,431],"their":[80],"intrinsic":[81],"characteristics,":[82],"inability":[83,247],"therapies":[85,434],"eliminate":[87],"all":[88],"also":[93,362],"reflects":[94],"a":[95,101],"contribution":[96],"by":[97,135],"microenvironmental":[98],"factors.":[99],"As":[100],"major":[102],"cellular":[103],"component":[104],"microenvironment,":[107],"associated":[109],"fibroblasts":[110],"(CAFs)":[111],"have":[112],"emerged":[113],"key":[116],"determinant":[117],"environmental":[119],"protection.":[120],"Many":[121],"in-vitro":[122,215,291],"studies":[123,193],"implicated":[124],"CAF-produced":[125],"paracrine":[126],"factors":[127],"can":[128,355],"dramatically":[129],"blunt":[130],"effect":[132],"TKIs":[134],"providing":[136],"alternative":[137],"mitogenic":[138],"survival":[140],"signals.":[141],"ability":[144],"CAFs":[146,184,204],"protect":[148],"from":[151,185,203,228],"TKI":[152],"well":[154,199],"documented":[155],"in-vitro,":[156],"whether":[157],"impact":[159,171,235],"stromal":[161,329,376,385,425],"protection":[162,214,238,330,345,377,426],"relevant":[164],"in-vivo":[165],"remains":[166],"unresolved.":[167],"To":[168,232],"study":[169,233],"CAF":[173,230],"response":[175,263,430],"ALK":[177,209,269,432],"TKI,":[178],"we":[179,194,243,261,294,310],"isolated":[180],"multiple":[181],"derivatives":[182],"patient\u2019s":[186],"resections.":[188],"Consistent":[189],"previously":[191],"reported":[192],"observed":[195,295],"that":[196,312,353],"co-culture":[197],"conditioned":[201],"media":[202],"protects":[205],"against":[208,402],"TKIs.":[210],"This":[211],"degree":[212],"was":[216,333,346],"highly":[217],"correlated":[218],"level":[221],"hepatocyte":[223],"growth":[224],"factor":[225],"(HGF)":[226],"measured":[227],"each":[229],"isolates.":[231],"HGF-mediated":[237],"in-vivo,":[242,319,378],"took":[244],"advantage":[245],"murine":[249],"HGF":[250,327],"activate":[252],"its":[253],"unique":[254],"receptor":[255],"cMET":[256],"human":[258],"cells.":[259],"Specifically,":[260],"compared":[262],"tumors":[265,273],"frontline":[268],"TKI:":[270],"alectinib":[271],"between":[272,302,382],"growing":[274],"regular":[276],"NSG":[277,283],"xenografts":[278],"those":[280],"grown":[281],"derivate":[284],"humanized":[286],"HGF.":[287],"Contrary":[288],"our":[290],"based":[292],"expectations,":[293],"only":[296,358],"minor":[297],"differences":[298,324],"responses":[301],"two":[304],"strains.":[305],"Using":[306],"spatial":[307],"histology":[308],"analyses,":[309],"found":[311],"rather":[313],"than":[314],"irrelevance":[315],"HGF-cMET":[317],"axis":[318],"this":[320,344],"lack":[321],"substantial":[323],"reflected":[325],"strong":[326],"independent":[328],"effect.":[331],"which":[332],"maintained":[334],"through":[335],"different":[336],"phases":[337],"responses,":[340],"including":[341],"relapse.":[342],"Surprisingly,":[343],"partially":[347],"retained":[348],"relapsing":[350],"tumors,":[351],"suggesting":[352],"stroma":[354],"contribute":[356],"persistence,":[360],"but":[361],"resistance.":[364,386],"Our":[365],"ongoing":[366],"efforts":[367],"focused":[369],"on":[370,380,427],"determining":[371],"what":[372],"molecular":[373],"mechanisms":[374],"underlying":[375],"interplay":[381],"cell-intrinsic":[383],"Addressing":[387],"these":[388],"questions":[389],"will":[390],"provide":[391],"knowledge":[392],"necessary":[393],"development":[396],"more":[398],"effective":[399],"therapeutic":[400],"strategies":[401],"ALK+":[403],"NSCLC.":[404],"Citation":[405],"Format:":[406],"Bina":[407],"Desai,":[408],"Viktoriya":[409],"Marusyk,":[410],"Daria":[411],"Miroshnychenko,":[412],"Chandler":[413],"Gatenbee,":[414],"Uwe":[415],"Rix,":[416],"Alexander":[417],"Anderson,":[418],"Eric":[419],"Haura,":[420],"Andriy":[421],"Marusyk.":[422],"Impact":[423],"vivo":[429],"targeted":[433],"[abstract].":[437],"In:":[438],"Proceedings":[439],"American":[442],"Association":[443],"Cancer":[445,456],"Research":[446],"Annual":[447],"Meeting":[448],"2022;":[449],"2022":[450],"Apr":[451],"8-13.":[452],"Philadelphia":[453],"(PA):":[454],"AACR;":[455],"Res":[457],"2022;82(12_Suppl):Abstract":[458],"nr":[459],"3193.":[460]},"counts_by_year":[],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2022-06-16T00:00:00"}